Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin

Journal of Clinical Pharmacology

Volumn 39, Issue 12, 1999, Pages 1283-1289

  Karol, M D ^a   Locke, C S ^a   Cavanaugh, J H ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; LANSOPRAZOLE; PHENYTOIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; ENZYME SUBSTRATE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

EID: 0033309228     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922011971     Document Type: Article

References (23)

1. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes
2. Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9
3. Co-regulation of phenytoin and tolbutamide metabolism in humans
4. Lansoprazole: A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders
5. Clinical pharmacokinetics of lansoprazole
6. Major implication of cytochrome P4503A4 in the oxidative metabolism of the antisecretory drugs omeprazole and lansoprazole in human liver microsomes and hepatocytes
7. Oxidative metabolism of lansoprazole by human liver cytochromes P450
8. Lack of effect of lansoprazole on warfarin pharmacokinetics and anticoagulation effect in healthy subjects
9. Lack of effect of concomitant lansoprazole on single-dose propranolol pharmacokinetics and pharmacodynamics
10. Lack of interaction of lansoprazole or omeprazole with prednisone
11. Influence of lansoprazole treatment on diazepam plasma concentrations
12. Omeprazole drug interaction studies
13. Effect of omeprazole and cimetidine treatment on plasma diazepam levels
14. Omeprazole inhibits oxidative drug metabolism: Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro
15. Oral phenytoin pharmacokinetics during omeprazole therapy
16. Review article: Omeprazole and the cytochrome P450 system
17. Identification of the human P450 enzymes involved in lansoprazole metabolism
18. Pharmacokinetic considerations in phenytoin pharmacotherapy: Preventing overdoses and underdoses
19. Recent advances: The cytochrome P450 enzymes
20. A study of the interaction between omeprazole and phenytoin in epileptic patients
21. Drug interactions of H2-receptor antagonists